<< Back to list

Novumed was appointed by the German government for "Innovations in medical technology" national strategy process.

Munich, 16. January 2012 - Germany's national strategy process "Innovations in medical technology"

Germany's national strategy process for medical technology is hosted by three ministries (Ministry of Health, Ministry of Business and Technology and Ministry of Research and Development). The executive committee is headed by three state secretaries and board members of leading medical technology companies (Siemens AG, Draegerwerk AG, Qiagen AG, B. Braun Melsungen AG, Biotronik SE, Philips Healthcare Germany, etc.). Novumed was appointed to this exclusive circle of experts, which was established by invitation only. Please find more information at: http://www.strategieprozess-medizintechnik.de.